Pramipexole ER 0,75 Teva


Extended release tablet
scheduling status
S4
registration number
50/5.4.1/0801
What Pramipexole ER 0,75 Teva contains
Pramipexole dihydrochloride monohydrate 0,75 mg which is equivalent to pramipexole 0,52 mg.
other ingredients
Colloidal silicon dioxide, dibasic calcium phosphate anhydrous, hypromellose 2208 fibrous powder, hypromellose 2208 granular powder and magnesium stearate.
Therapeutic classification
N04B C05 - dopamine agonists (specifically stimulating dopamine receptors).
© 2026 SAHPRA. ALL RIGHTS RESERVED